1 / 2

Genomics Research & Intellectual Property Analysis: Policymaking & Commercialization Perspectives

Explore the intersection of genomics research, intellectual property, and policy making for effective commercialization. Discuss the key policy objectives, R&D investments, business-academia collaborations, and venture capital in this evolving landscape. Dive into the challenges, weaknesses, and opportunities in commercializing university research discoveries. Look ahead to future case studies for optimal IP strategies in genomics.

shirin
Télécharger la présentation

Genomics Research & Intellectual Property Analysis: Policymaking & Commercialization Perspectives

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Genomics Research and Intellectual PropertyApril 28, 2011 Marshall Moffat President mc squared Professional Services

  2. Commentary From The Policymakers’ Perspective • About me • Bouquet • Policymaking is a multi-splendored thing • Federal policymaker perspectives • The big eight policy objectives (economy, international, health, environment, social, justice and security, governance, Aboriginal peoples) • Innovation economic policy framework (Marketplace and Trade, Knowledge and R&D investment, Innovation and Entrepreneurs, People) • R&D policy and investment (SRED, Granting Agencies and Foundations, Govt Science, IRAP etc.) • Commercialization problem and expectation (pay-off) • Key commercialization weaknesses • Business/academe collaboration • Venture capital • First market (e.g. CICP) • Genomics / IP Management Bottom line • No one size fits all • Gestation periods affect what works best (amount of knowledge networking and/or business case development required) • Options 1, 2 and 3 • ICT vs Genomic research; different types of genomics research • Commercialization of university research discoveries • Two solitudes (business and academe, receptors and publish or perish) • The NCE Programs and ex-ante collaboration • Venture Capital and first market • Future Work: Case studies to develop a model for determining optimum IP approaches • ICT vs Genomics • Characteristics for different types of genomics research

More Related